ELOVL4 and Alzheimer disease: Last but not least, recent studies on normal human cultured keratinocytes of AD and mice models show that IFN-γ significantly reduces ELOVL4, which may be one of the key findings explaining the mechanism of the chronicity of barrier function impairment in AD (63, 64).